In vivo animal tests of an artifact-free contrast agent for gastrointestinal MRI.
A variety of shortcomings are associated with most currently used gastrointestinal contrast agents for magnetic resonance imaging (MRI). Artifacts resulting from peristalsis and other motions in the abdominal region are produced by many positive contrast agents (which increase signal intensity). Although this is not a problem for negative contrast agents (which decrease signal intensity), some negative contrast agents produce magnetic susceptibility artifacts that are especially pronounced at high field strength and with gradient echo pulse sequences. These susceptibility artifacts are produced by both paramagnetic and diamagnetic agents. It has been demonstrated in phantoms, however, that susceptibility matching can be used to produce contrast agents with desirable relaxation and contrast properties but without deleterious susceptibility artifacts. We now report results of animal tests of such an oral contrast agent, consisting of a suspension of superparamagnetic iron oxide particles and diamagnetic barium sulfate particles, compared to individual suspensions of the iron oxide and of the barium sulfate. Iron oxide was the least effective and the matched susceptibility mixture was the most effective for the intestine, which has traditionally been the most difficult region of the GI tract to visualize clearly. Matched susceptibility mixtures, which are inherently able to yield images free of susceptibility artifacts without compromising contrast, show promise of being improved oral negative contrast agents for use in gastrointestinal MRI.
Briggs
R W
RW
Department of Radiology, University of Florida, Gainesville 32610, USA. rbriggs@ufnmr1.health.ufl.edu
Wu
Z
Z
Mladinich
C R
CR
Stoupis
C
C
Gauger
J
J
Liebig
T
T
Ros
P R
PR
Ballinger
J R
JR
Kubilis
P
P
D000284:Administration, Oral; D000818:Animals; D001466:Barium Sulfate / Q000008:administration & dosage; D003287:Contrast Media / Q000008:administration & dosage*; D052203:Ferrosoferric Oxide; D007422:Intestines / Q000033:anatomy & histology* / Q000473:pathology; D007501:Iron / Q000008:administration & dosage; D008279:Magnetic Resonance Imaging / Q000379:methods; D008280:Magnetics; D008297:Male; D010087:Oxides / Q000008:administration & dosage; D051381:Rats; D017207:Rats, Sprague-Dawley; D013270:Stomach / Q000033:anatomy & histology* / Q000473:pathology
D003287:Contrast Media; D010087:Oxides; D001466:Barium Sulfate; D007501:Iron; D052203:Ferrosoferric Oxide